1632
O. M. Abdelhafez et al.
M., Macías, B., Borrás, J., and Alzuet, G., Toward the de-
thiazolidin-4-ones as non-nucleoside HIV-1 reverse tran-
scriptase inhibitors. Antiviral Res., 63, 79-84 (2004).
Rescifina, A., Chiacchio, M. A., Corsaro, A., De Clercq, E.,
Iannazzo, D., Mastino, A., Piperno, A., Romeo, G., Romeo,
R., and Valveri, V., Synthesis and biological activity of
isoxazolidinyl polycyclic aromatic hydrocarbons: potential
DNA intercalators. J. Med. Chem., 49, 709-715 (2006).
Rida, S. M., El-Hawash, S. A., Fahmy, H. T., Hazzaa, A. A.,
and El-Meligy, M. M., Synthesis of novel benzofuran and
related benzimidazole derivatives for evaluation of in
vitro anti-HIV-1, anticancer and antimicrobial activities.
Arch. Pharm. Res., 29, 826-833 (2006).
velopment of metal-based synthetic nucleases: DNA bind-
ing and oxidative DNA cleavage of a mixed copper(II)
complex with N-(9H-purin-6-yl)benzenesulfonamide and
1,10-phenantroline. Antitumor activity in human Caco-2
cells and Jurkat T lymphocytes. Evaluation of p53 and
Bcl-2 proteins in the apoptotic mechanism. J. Inorg.
Biochem., 103, 923-934 (2009).
Hishmat, O. H., Mustafa, A., and Younes, M. M. Y., Mannich
reaction of 1(4,6-dimethoxybenzofuranyl) and 1-(4,6-7-tri-
methoxybenzofuranyl) butan-1,2,3-trione-2-aryl hydrazone.
Ind. J. Chem., 9, 893-894 (1971).
Kamal, A., Shankaraiah, N., Prabhakar, S., Reddy, Ch. R.,
Markandeya, N., Reddy, K. L., and Devaiah, V., Solid-phase
synthesis of new pyrrolobenzodiazepine-chalcone conjugates:
DNA-binding affinity and anticancer activity. Bioorg.
Med. Chem. Lett., 18, 2434-2439 (2008).
Schönberg, A. and Aziz, G., Furochromones and coumarins.
VI. Demethylation of xanthotoxin, khellin and khellol
with aniline hydrochloride and magnesium iodide. J. Am.
Chem. Soc., 75, 3265-3266 (1953).
Scozzafava, A., Owa, T., Mastrolorenzo, A., and Supuran, C.
Kochetkov, N. K. and Sokolov, S. D., In Katritzky, A. R.
(Ed.), Advances in Heterocyclic Chemistry. Academic
press, New York, Vol. 2, pp. 365-422, (1963).
T., Anticancer and antiviral sulfonamides. Curr. Med.
Chem., 10, 925-953 (2003).
Shivarama Holla, B., Veerendra, B., Shivananda, M. K., and
Poojary, B., Synthesis characterization and anticancer
activity studies on some Mannich bases derived from 1,2,4-
triazoles. Eur. J. Med. Chem., 38, 759-767 (2003).
Sriram, D., Yogeeswari, P., and Kumar, T. G., Microwave-
assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-
thiazolidin-4-ones. J. Pharm. Pharm. Sci., 8, 426-429 (2005).
Starkowsky, N. A., Addition of urea, thiourea and iodine to
the natural benzopyrones of Ammi visnaga Linn. and
Ammi majus linn. Egypt J. Chem., 2, 111-117 (1959).
Tan, J. H., Zhang, Q. X., Huang, Z. S., Chen, Y., Wang, X. D.,
Gu, L. Q., and Wu, J. Y., Synthesis, DNA binding and
cytotoxicity of new pyrazole emodin derivatives. Eur. J.
Med. Chem., 41, 1041-1047 (2006).
Lee, J. K., Jung, J. S., Park, S. H., Park, S. H., Sim, Y, B.,
Kim, S. M., Ha, T. S., and Suh, H. W., Anti-inflammatory
effect of visnagin in lipopolysaccharide-stimulated BV-2
microglial cells. Arch. Pharm. Res., 33, 1843-1850 (2010).
Lv, P. C., Zhou, C. F., Chen, J., Liu, P. G., Wang, K. R., Mao,
W. J., Li, H. Q., Yang, Y., Xiong, J., and Zhu, H. L., Design,
synthesis and biological evaluation of thiazolidinone
derivatives as potential EGFR and HER-2 kinase inhibi-
tors. Bioorg. Med. Chem., 18, 314-319 (2010).
Mandour, A. H., Abu-Mustafa, E. A., Abdel-Latif, N. A., and
El-Bazza, Z. E., Synthesis and biological evaluation of
some new visnagin and benzofuran derivatives. Al-Azhar
Bull. Sci., 5, 983-993 (1994).
Mijatovic, T., De Nève, N., Gailly, P., Mathieu, V., Haibe-
Kains, B., Bontempi, G., Lapeira, J., Decaestecker, C.,
Facchini, V., and Kiss, R., Nucleolus and c-Myc: potential
targets of cardenolide-mediated antitumor activity. Mol.
Cancer Ther., 7, 1285-1296 (2008).
Terziog˘lu, N., Karali, N., Gürsoy, A., Pannecouque, C.,
Leysen, P., Paeshuyse, J., Neyts, J., and De Clercq, E.,
Synthesis and primary antiviral activity evaluation of 3-
hydrazono-5-nitro-2-indolinone derivatives. ARKIVOC, (i),
109-118 (2006).
Park, H. J., Lee, K., Park, S. J., Ahn, B., Lee, J. C., Cho, H.,
and Lee, K. I., Identification of antitumor activity of
pyrazole oxime ethers. Bioorg. Med. Chem. Lett., 15, 3307-
3312 (2005).
Ragab, F. A., Hassan, G. S., Yossef, H. A., and Hashem, H.
A., Synthesis of 6- and 9-alkylaminomethyl furoflavones
as gastroprotective agents. Eur. J. Med. Chem., 42, 1117-
1127 (2007).
Wenzel, N. I., Chavain, N., Wang, Y., Friebolin, W., Maes,
L., Pradines, B., Lanzer, M., Yardley, V., Brun, R., Herold-
Mende, C., Biot, C., Tóth, K., and Davioud-Charvet, E.,
Antimalarial versus cytotoxic properties of dual drugs
derived from 4-aminoquinolines and Mannich bases:
interaction with DNA. J. Med. Chem., 53, 3214-3226 (2010).
Wu, S., Guo, W., Teraishi, F., Pang, J., Kaluarachchi, K., Zhang,
L., Davis, J., Dong, F., Yan, B., and Fang, B., Anticancer
activity of 5-benzylidene-2-phenylimino-1,3-thiazolidin-4-
one (BPT) analogs. Med. Chem., 2, 597-605 (2006).
Rao, A., Balzarini, J., Carbone, A., Chimirri, A., De Clercq,
E., Monforte, A. M., Monforte, P., Pannecouque, C., and
Zappalà, M., 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-